ABSTRACT
Autoantibodies are frequently reported in patients with malaria, but whether they contribute to protection or to pathology is an issue of debate. A large body of evidence indicates that antibodies against host-self components are associated to malaria clinical outcomes such as cerebral malaria, renal dysfunction and anemia. Nonetheless, self-reactive immunoglobulins induced during an infection can also mediate protection. In light of these controversies, we summarize here the latest findings in our understanding of autoimmune responses in malaria, focusing on Plasmodium falciparum and Plasmodium vivax. We review the main targets of self-antibody responses in malaria as well as the current, but still limited, knowledge of their role in disease pathogenesis or protection.
Subject(s)
Malaria, Falciparum , Malaria, Vivax , Autoantibodies , Humans , Plasmodium falciparum , Plasmodium vivaxABSTRACT
Autoantibodies play an important role in the destruction of non-infected red blood cells (nRBCs) during malaria. However, the relationship between this clearance and ABO blood groups is yet to be fully enlightened, especially for Plasmodium vivax infections. Here we show that anti-RBC IgG and IgM are increased in anemic patients with acute vivax malaria. Furthermore, both antibodies are able to decrease the deformability of nRBCs, but only IgG can induce in vitro erythrophagocytosis. Such effects are enhanced in type O erythrocytes, suggesting that individuals from this blood group infected with P. vivax malaria may be more susceptible to develop anemia.
Subject(s)
ABO Blood-Group System/immunology , Anemia/immunology , Autoantibodies/immunology , Erythrocytes/immunology , Immunoglobulin G/immunology , Immunoglobulin M/immunology , Malaria, Vivax/immunology , Anemia/etiology , Anemia/pathology , Cell Membrane/pathology , Disease Susceptibility , Erythrocytes/pathology , Humans , Malaria, Vivax/complications , Malaria, Vivax/pathology , Phagocytosis , Plasmodium vivaxABSTRACT
Anti-α-Gal responses may exert a protective effect in falciparum malaria. However, the biological role of such antibodies is still unknown during Plasmodium vivax infections. We investigated IgG and IgM responses to α-Gal in individuals with vivax malaria. Anti-α-Gal IgG and IgM levels were higher in these patients than in controls, but no significant correlation was found between parasitaemia and anti-α-Gal response, nor between this response and ABO blood group status. This is the first study to investigate anti-α-Gal antibodies in P. vivax-infected patients; a larger survey is necessary to achieve a better understanding of host immune response during vivax malaria.
Subject(s)
Antibodies, Anti-Idiotypic/blood , Immunoglobulin G/blood , Immunoglobulin M/blood , Malaria, Vivax/blood , Plasmodium vivax/immunology , Adult , Antibodies, Anti-Idiotypic/metabolism , Humans , Immunoglobulin G/immunology , Immunoglobulin M/immunology , Malaria, Vivax/immunology , Middle Aged , Young AdultABSTRACT
Anti-α-Gal responses may exert a protective effect in falciparum malaria. However, the biological role of such antibodies is still unknown during Plasmodium vivax infections. We investigated IgG and IgM responses to α-Gal in individuals with vivax malaria. Anti-α-Gal IgG and IgM levels were higher in these patients than in controls, but no significant correlation was found between parasitaemia and anti-α-Gal response, nor between this response and ABO blood group status. This is the first study to investigate anti-α-Gal antibodies in P. vivax-infected patients; a larger survey is necessary to achieve a better understanding of host immune response during vivax malaria.
